This brand name is authorized in Austria, Ecuador.
The drug GYNODIAN DEPOT contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
2W8I1S6T5L - PRASTERONE ENANTATE
|
|
Prasterone, i.e. dehydroepiandrosterone (DHEA), biochemically and biologically identical to the endogenous human DHEA, is a precursor steroid which is inactive by itself and it is converted into oestrogens and androgens. Intrarosa is thus different from the oestrogens preparations since it delivers also androgen metabolites. |
|
2
|
UNII
OKG364O896 - ESTRADIOL VALERATE
|
|
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G03EA03 | Prasterone and estrogen | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03E Androgens and female sex hormones in combination → G03EA Androgens and estrogens |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 364430213 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.